source
- Vertex and AbCellera team up to develop next-generation T-cell engagers for autoimmune diseasesVertex Pharmaceuticals has entered a partnership with AbCellera to create next-generation T-cell engagers aimed at autoimmune diseases. AbCellera will receive an upfront payment of $28 million, wit…
- Anthony Fauci’s pandemic-era diary entriesNew data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds